| Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro … FA Iannotti, CL Hill, A Leo, A Alhusaini, C Soubrane, E Mazzarella, ... ACS chemical neuroscience 5 (11), 1131-1141, 2014 | 414 | 2014 |
| Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity P Ventrice, D Ventrice, E Russo, G De Sarro Environmental toxicology and pharmacology 36 (1), 88-96, 2013 | 341 | 2013 |
| Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug–Drug Interactions E Russo, F Scicchitano, BJ Whalley, C Mazzitello, M Ciriaco, S Esposito, ... Phytotherapy research 28 (5), 643-655, 2014 | 275 | 2014 |
| Corticosteroid-related central nervous system side effects M Ciriaco, P Ventrice, G Russo, M Scicchitano, G Mazzitello, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S94-S98, 2013 | 260 | 2013 |
| Metformin and autoimmunity: a “new deal” of an old drug F Ursini, E Russo, G Pellino, S D’Angelo, A Chiaravalloti, G De Sarro, ... Frontiers in immunology 9, 1236, 2018 | 191 | 2018 |
| Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta‐analysis of risk factors E Ferlazzo, S Gasparini, E Beghi, C Sueri, E Russo, A Leo, A Labate, ... Epilepsia 57 (8), 1205-1214, 2016 | 185 | 2016 |
| Adherence to therapy and adverse drug reactions: is there a link? C Leporini, G De Sarro, E Russo Expert opinion on drug safety 13 (sup1), 41-55, 2014 | 182 | 2014 |
| mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis R Citraro, A Leo, A Constanti, E Russo, G De Sarro Pharmacological research 107, 333-343, 2016 | 176 | 2016 |
| Microbiota-gut brain axis involvement in neuropsychiatric disorders LF Iannone, A Preda, HM Blottière, G Clarke, D Albani, V Belcastro, ... Expert review of neurotherapeutics 19 (10), 1037-1050, 2019 | 166 | 2019 |
| Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy M Ammendola, C Leporini, I Marech, CD Gadaleta, G Scognamillo, ... BioMed research international 2014 (1), 154702, 2014 | 140 | 2014 |
| mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy E Russo, R Citraro, G Donato, C Camastra, R Iuliano, S Cuzzocrea, ... Neuropharmacology 69, 25-36, 2013 | 137 | 2013 |
| Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports C Palleria, C Leporini, S Chimirri, G Marrazzo, S Sacchetta, L Bruno, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S66-S72, 2013 | 119 | 2013 |
| Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy R Citraro, E Russo, F Scicchitano, CM van Rijn, D Cosco, C Avagliano, ... Neuropharmacology 69, 115-126, 2013 | 117 | 2013 |
| Cannabidiol and epilepsy: Rationale and therapeutic potential A Leo, E Russo, M Elia Pharmacological research 107, 85-92, 2016 | 114 | 2016 |
| Upholding WAG/Rij rats as a model of absence epileptogenesis: Hidden mechanisms and a new theory on seizure development E Russo, R Citraro, A Constanti, A Leo, A Lüttjohann, G van Luijtelaar, ... Neuroscience & Biobehavioral Reviews 71, 388-408, 2016 | 113 | 2016 |
| Rare and very rare adverse effects of clozapine P De Fazio, R Gaetano, M Caroleo, G Cerminara, F Maida, A Bruno, ... Neuropsychiatric disease and treatment, 1995-2003, 2015 | 113 | 2015 |
| The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis E Russo, R Citraro, A Constanti, G De Sarro Molecular neurobiology 46, 662-681, 2012 | 105 | 2012 |
| Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist R Gitto, ML Barreca, L De Luca, G De Sarro, G Ferreri, S Quartarone, ... Journal of medicinal chemistry 46 (1), 197-200, 2003 | 103 | 2003 |
| Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects C Palleria, A Leo, F Andreozzi, R Citraro, M Iannone, R Spiga, G Sesti, ... Behavioural brain research 321, 157-169, 2017 | 101 | 2017 |
| Pharmacovigilance in Italy: an overview C Mazzitello, S Esposito, AE De Francesco, A Capuano, E Russo, ... Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S20-S28, 2013 | 101 | 2013 |